Sort
35,931 grants matching “parkinsons”
Dopamine Genetic Variants Modulating Recovery After TBI
$362,526Amy K Wagner · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · HD
Studying Aggregation in Neurodegenerative Disease Using Synthetic Proteins
$362,510Ernest James Petersson · University Of Pennsylvania · R01 · FY2022 · NS
Real-time statistical algorithms for controlling neural dynamics and behavior
$362,509Il Memming Park · State University New York Stony Brook · R01 · FY2020 · EB
Real-time statistical algorithms for controlling neural dynamics and behavior
$362,509Il Memming Park · State University New York Stony Brook · R01 · FY2019 · EB
Neuronal Plasticity in the Retina
$362,500Ohio State University · R01 · FY2005 · EY
Cell Grafts for Parkinson's Disease
$362,500Rush University Medical Center · R01 · FY2004 · NS
Cell Grafts for Parkinson's Disease
$362,500Rush University Medical Center · R01 · FY2003 · NS
Cell Grafts for Parkinson's Disease
$362,500Rush University Medical Center · R01 · FY2002 · NS
Modulation of Cav 1.3 L-type Ca2+ channels by PDZ-protein interactions
$362,500Amy Lee · University Of Iowa · R01 · FY2011 · HL
Neuronal Plasticity in the Retina
$362,500University Of Alabama At Birmingham · R01 · FY2004 · EY
Neuron-glial interactions within the basal ganglia
$362,495Antonello Bonci · National Institute On Drug Abuse · ZIA · FY2017 · DA
The molecular basis of cardiolipin-protein interactions implicated in intrinsic apoptosis
$362,488Patrick C.a. Van Der Wel · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · GM
Functionalized Congeners Of Bioactive Compounds
$362,442Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo
$362,440Sylvia Fitting · Univ Of North Carolina Chapel Hill · R01 · FY2021 · DA
The Rat Pre-Formed Alpha-Synuclein Fibril Model of Parkinson's Disease
$362,411Caryl E Sortwell · Michigan State University · R33 · FY2019 · NS
Genome wide SNP analysis in Parkinson's disease
$362,404Andrew Singleton · National Institute On Aging · ZIA · FY2011 · AG
Neurotransmitter Mechanisms in the Mammalian Retina
$362,399Stephen C. Massey · University Of Texas Hlth Sci Ctr Houston · R01 · FY2008 · EY
Pro-Leu-Gly-NH2 and Dopamine Receptor Modulation
$362,371University Of Minnesota Twin Cities · R01 · FY2003 · NS
Mimicry of Amyloid Oligomers
$362,297James S Nowick · University Of California-Irvine · R01 · FY2016 · GM
XIAP Gene Therapy in Huntington's Disease
$362,294Michael G Kaplitt · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · NS
Diffusion of Substances Through the Brain
$362,294Charles Nicholson · New York University School Of Medicine · R01 · FY2012 · NS
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease
$362,294Thomas M Wisniewski · New York University School Of Medicine · R01 · FY2012 · NS
Role of MyD88-5 in the pathogenesis of Parkinson's disease
$362,294Bobby Thomas · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · NS
XIAP Gene Therapy in Huntington's Disease
$362,294Michael G Kaplitt · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · NS
Diffusion of Substances Through the Brain
$362,294Charles Nicholson · New York University School Of Medicine · R01 · FY2011 · NS